Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00573378
Title Imatinib or Nilotinib With Pegylated Interferon-alpha2b in Chronic Myeloid Leukemia
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications

chronic myeloid leukemia

Therapies

Imatinib + Interferon alpha-2b

Interferon alpha-2b + Nilotinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.